metronidazole has been researched along with quinine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Azam, A; Hayat, F; Moseley, E; Salahuddin, A; Van Zyl, RL | 1 |
| Agarwal, SM; Avecilla, F; Azam, A; Chen, CT; Heslop, DC; Inam, A; Salahuddin, A; van Zyl, RL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahmad, K; Ansari, MF; Azam, A; Coetzee, M; Hayat, F; Inam, A; Kathrada, F; Shin, D; van Zyl, RL | 1 |
| Takada, S | 1 |
| Clancy, CF | 1 |
| Carter, RF | 1 |
| Suzuki, M | 1 |
| Nakajima, Y | 1 |
| Aguilera-Alonso, D; Del Rosal, T; Escosa-García, L; García-Hortelano, M; López Medina, EM; Villota Arrieta, J | 1 |
4 review(s) available for metronidazole and quinine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Neurological toxicity of antifungal and antiprotozoal drugs].
Topics: Amphotericin B; Antifungal Agents; Antimalarials; Antiprotozoal Agents; Antitrichomonal Agents; Central Nervous System Diseases; Chloroquine; Humans; Mefloquine; Metronidazole; Quinine | 1999 |
[Antiprotozoal drugs].
Topics: Animals; Antiprotozoal Agents; Drug Combinations; Emetine; Humans; Mefloquine; Metronidazole; Phenanthrenes; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Sulfadoxine; Tinidazole | 2003 |
Acalculous Cholecystitis in a Pediatric Patient With Plasmodium Falciparum Infection: A Case Report and Literature Review.
Topics: Acalculous Cholecystitis; Acute Kidney Injury; Administration, Intravenous; Anti-Bacterial Agents; Antimalarials; Cefotaxime; Child, Preschool; Clindamycin; Female; Humans; Malaria, Falciparum; Metronidazole; Plasmodium falciparum; Quinine; Thrombocytopenia | 2018 |
14 other study(ies) available for metronidazole and quinine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antiprotozoal activity of chloroquinoline based chalcones.
Topics: Antiprotozoal Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Entamoeba histolytica; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis and evaluation of 7-chloro-4-(piperazin-1-yl)quinoline-sulfonamide as hybrid antiprotozoal agents.
Topics: Amino Acid Sequence; Antiprotozoal Agents; Cell Survival; Chloroquine; Crystallography, X-Ray; Dihydropteroate Synthase; Drug Resistance; Entamoeba histolytica; Erythrocytes; Hemeproteins; Hemolysis; Humans; Molecular Docking Simulation; Molecular Sequence Data; Piperazines; Plasmodium falciparum; Protozoan Proteins; Quinine; Quinolines; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
New antiprotozoal agents: Synthesis and biological evaluation of different 4-(7-chloroquinolin-4-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone derivatives.
Topics: Antimalarials; Antiprotozoal Agents; Binding Sites; Cell Line; Cell Survival; Chloroquine; Entamoeba histolytica; Erythrocytes; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Piperazine; Piperazines; Plasmodium falciparum; Protein Structure, Tertiary; Protozoan Proteins; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2017 |
[Drugs used against protozoan infections in man].
Topics: Amebiasis; Aminoquinolines; Antiprotozoal Agents; Humans; Malaria; Metronidazole; Pneumonia, Pneumocystis; Pyrimethamine; Quinine; Suramin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Trypanosomiasis | 1990 |
The lethal effect of certain antimalarial drugs on Tetrahymena pyriformis.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Metronidazole; Nitrofurantoin; Penicillins; Primaquine; Proguanil; Quinacrine; Quinine; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetrahymena | 1968 |
Sensitivity to amphotericin B of a Naegleria sp. isolated from a case of primary amoebic meningoencephalitis.
Topics: Amebiasis; Amoeba; Amphotericin B; Animals; Chloramphenicol; Emetine; Humans; Meningoencephalitis; Methotrexate; Metronidazole; Mice; Oxytetracycline; Penicillins; Quinine; Streptomycin; Sulfadiazine | 1969 |